A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab.
Hidetoshi KokubunToshiki KijimaAtsuko Takada-OwadaDaisuke MamiyaRyo KurashinaNaoya OkuboToshitaka UematsuKohei TakeiKazuyuki IshidaTakao KamaiPublished in: IJU case reports (2023)
Immunohistochemical analysis focusing on tertiary lymphoid structures and genome profiling to evaluate microsatellite instability and tumor mutation burden are essential for precision medicine and informed clinical decision-making when treating advanced undifferentiated pleomorphic sarcoma.